Paper8575136
Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study.
Spadaro A and 5 others. Clin Exp Rheumatol, 1995. Cited by 103 papers, by iCite.
Cite this record
ConductScience Library. Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study. Papers, record 8575136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8575136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antirheumatic Agents | Major topic |
| Arthritis, Psoriatic | Major topic |
| Cyclosporine | Major topic |
| Methotrexate | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Dose-Response Relationship, Drug | |
| Drug Administration Schedule | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Treatment Outcome |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 103 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34819174 | Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis. | Adv Rheumatol | 2021 | https://conductscience.org/library/papers/34819174 | PubMed |
| 33934175 | Management of particular clinical situations in psoriatic arthritis: an expert's recommendation document based on systematic literature review and extended Delphi process. | Rheumatol Int | 2021 | https://conductscience.org/library/papers/33934175 | PubMed |
| 30656673 | Methotrexate for psoriatic arthritis. | Cochrane Database Syst Rev | 2019 | https://conductscience.org/library/papers/30656673 | PubMed |
| 28293446 | Real-life experience of using conventional disease-modifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Retrospective analysis of the efficacy of methotrexate, sulfasalazine, and leflunomide in PsA in comparison to spondyloarthritides other than PsA and literature review of the use of conventional DMARDs in PsA. | Eur J Rheumatol | 2017 | https://conductscience.org/library/papers/28293446 | PubMed |
| 27515671 | The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review. | Clin Rev Allergy Immunol | 2017 | https://conductscience.org/library/papers/27515671 | PubMed |
| 22344575 | A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. | Rheumatology (Oxford) | 2012 | https://conductscience.org/library/papers/22344575 | PubMed |
| 21979255 | [Psoriatric arthritis - a permanent challenge for rheumatologists and patients: part 2: imaging diagnostics, classification and therapy]. | Z Rheumatol | 2011 | https://conductscience.org/library/papers/21979255 | PubMed |
| 21272347 | Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study. | Arthritis Res Ther | 2011 | https://conductscience.org/library/papers/21272347 | PubMed |
| 19691930 | Update on the treatment of peripheral arthritis in psoriatic arthritis. | Curr Rheumatol Rep | 2009 | https://conductscience.org/library/papers/19691930 | PubMed |
| 18177596 | Psoriatic arthritis: current topics. | Curr Rheumatol Rep | 2007 | https://conductscience.org/library/papers/18177596 | PubMed |
| 17102998 | [Therapy for secondary arthropathies: from psoriasis and Reiter's disease to hemochromatosis]. | Internist (Berl) | 2006 | https://conductscience.org/library/papers/17102998 | PubMed |
| 17038465 | Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006. | Ann Rheum Dis | 2006 | https://conductscience.org/library/papers/17038465 | PubMed |
| 16239380 | Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005. | Ann Rheum Dis | 2005 | https://conductscience.org/library/papers/16239380 | PubMed |
| 15916449 | Traditional and newer therapeutic options for psoriatic arthritis: an evidence-based review. | Drugs | 2005 | https://conductscience.org/library/papers/15916449 | PubMed |
| 15708943 | Psoriatic arthritis therapy: NSAIDs and traditional DMARDs. | Ann Rheum Dis | 2005 | https://conductscience.org/library/papers/15708943 | PubMed |
| 15528283 | A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis. | Ann Rheum Dis | 2005 | https://conductscience.org/library/papers/15528283 | PubMed |
| 15479866 | Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004. | Ann Rheum Dis | 2004 | https://conductscience.org/library/papers/15479866 | PubMed |
| 12421102 | Diagnosis and management of psoriatic arthritis. | Drugs | 2002 | https://conductscience.org/library/papers/12421102 | PubMed |
| 11890649 | Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha. | Ann Rheum Dis | 2001 | https://conductscience.org/library/papers/11890649 | PubMed |
| 11830424 | Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up. | Ann Rheum Dis | 2002 | https://conductscience.org/library/papers/11830424 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8575136
GET https://conductscience.org/api/papers/v1/8575136/cited_by?page=2